GLOW

GLOW is not a compound. It is a formulated blend of three separate peptides presented in a single vial: GHK-Cu, BPC-157 and TB-500. Each of those is cataloged individually by VaultLabs and has its own monograph. The blend exists so a laboratory can study the combination as a matrix, not so three certificates can be collapsed into one.

The distinction between a compound and a blend matters more than it might appear. A single substance has a CAS registry number, a molecular formula, a defined mass and a meaningful purity percentage. A three-component mixture has none of those things as a whole. Suppliers that publish a CAS number or a single purity figure for a blend are, at best, describing one component and implying it covers all of them.

VaultLabs therefore lists no CAS number for GLOW. That is a deliberate accuracy decision rather than missing data, consistent with how the catalog handles KLOW and other multi-component materials.

GLOW is a 70 mg three-component presentation without KPV. KLOW adds KPV as a fourth component at an 80 mg fill. Wolverine is BPC-157 plus TB-500 only — no GHK-Cu. Those are independent SKUs with independent lots and certificates.

Choose GLOW when the research design calls for the copper-tripeptide plus the two repair-class sequences and does not require KPV. Choose KLOW when KPV is part of the design. Choose the individual components when the work is about one sequence and the certificate must describe that sequence unambiguously.

Lots and certificates are never shared across GLOW, KLOW, Wolverine, or the single-sequence vials. A label that names GLOW but a certificate written for KLOW, or for GHK-Cu alone, is a receiving error and should be queried before the material enters an experiment.

For a composite material, the analytically meaningful questions are different from those for a single peptide. Are all three named components actually present? In what ratio? Is each one identifiable against its own reference standard? A chromatogram of a three-peptide mixture should resolve three species, and a certificate should let you connect each peak to a named component.

A laboratory intending to draw conclusions about any individual component is almost always better served by ordering that component separately, where the certificate describes one substance unambiguously. Blends are appropriate where the combination itself is the object of study.

It is also worth noting that the published literature for each constituent was generated using that constituent alone. There is no body of work establishing how GHK-Cu, BPC-157 and TB-500 behave together, and combining literature from three separate sources to describe a mixture is not a sound inference.

A mixture inherits the strictest handling requirement of any component, and it does so silently. GHK-Cu contributes a metal complex that is sensitive to chelating buffer components and to pH, and it is what gives the cake its blue-green to purple colour. TB-500 contributes a short fragment that is prone to oxidation once a vial is open. BPC-157 contributes conventional peptide constraints on hydrolysis and freeze-thaw cycling.

The practical result is that any single condition tolerable for two of the three components can still degrade the third, and a chromatogram of the blend will not necessarily make that obvious unless the method resolves all three species cleanly. Stability determinations made for an individual peptide do not transfer to the blend.

Store sealed lyophilised vials at 2–8 °C, protected from light and humidity, and equilibrate to room temperature before opening. Avoid chelating buffer components because of the copper complex. Minimise open-vial time and freeze-thaw cycles.

Two of the named components — BPC-157 and TB-500 — are prohibited in sport under the World Anti-Doping Agency list. A laboratory connected to athlete populations or testing programmes should treat the blend as carrying those same constraints.

GLOW is not an approved medicine in any jurisdiction and is not supplied for human or veterinary use. Orders are accepted against a research-use declaration retained in the order record. This monograph is a reference article for laboratory purchasers and documentation staff. It is not a protocol and not a substitute for institutional SOP review.

Where papers on the individual constituents are cited, they anchor component identity only. They do not describe this combination, they do not authorise human use of VaultLabs research material, and they do not convert a lyophilised reference vial into a finished medicine. If a certificate, label and monograph appear to disagree, stop and query support with the lot number before the material enters an experiment.

Multi-component copper peptide + repair peptide documentation

Blend identity and ratio analytics

Comparative three-vs-four component handling workflows

2–8 °C (lyophilized, sealed)

2–8 °C sealed; follow product page and batch COA notes.

Blend materials inherit the strictest handling constraints of any component — sealed cold storage and gentle reconstitution.